The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease ...

Wrist-worn devices can predict imminent inflammatory and symptomatic inflammatory bowel disease flare-ups as far in advance ...

Discover how wearable devices like Apple Watches and Fitbits can detect signs of IBD flares weeks before symptoms appear, ...

People with the skin condition psoriasis often have invisible inflammation in the small intestine with an increased propensity for 'leaky gut', according to new research. These changes in the gut ...

People with the skin condition psoriasis often have invisible inflammation in the small intestine with an increased ...

The FDA has approved Omvoh (mirikizumab-mrkz) for treating moderately to severely active Crohn’s disease in adults. Clinical ...

More than half (53%) of patients reached remission after one year of Omvoh treatment and 46% experienced healing of the ...

Jabeur, ranked 39, needed a medical timeout on her way to a 7-5, 6-3 victory over Colombia's Camila Osorio for treatment and to use an inhaler. "Very, very tough to breathe. When I was younger ...

(RTTNews) - Eli Lilly and Co. (LLY) announced that the U.S. Food and Drug Administration has approved Omvoh (mirikizumab-mrkz) for the treatment of moderately to severely active Crohn's disease in ...

Understanding these symptoms is crucial for early diagnosis, effective treatment ... symptom of both Crohn’s disease and ulcerative colitis, especially during flare-ups. This is often ...

Wearable devices can identify, differentiate, and predict flare-ups, or the worsening of symptoms and inflammation, in inflammatory bowel disease (IBD), Mount Sinai researchers have shown in a ...

Some may experience it for a year, months, or days. A flare can last as long as there isn't a change in treatment. In one study, flares lasted longer than two weeks in 30% of participants, one to two ...